Technology

Avadel Pharmaceuticals

$6.73
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.03 (-0.44%) As of 4:02 PM UTC today

Why Robinhood?

You can buy or sell AVDL and other stocks, options, and ETFs commission-free!

About AVDL

Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. It offers Bloxiverz, Vazculep, and Akovaz. The company was founded on December 1, 2015 and is headquartered in Dublin, Ireland. The listed name for AVDL is Avadel Pharmaceuticals plc American Depositary Shares.

CEO
Gregory J. Divis
Employees
50
Headquarters
Dublin, Dublin
Founded
2015
Market Cap
387.10M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
338.27K
High Today
$6.76
Low Today
$6.53
Open Price
$6.76
Volume
46.51K
52 Week High
$13.49
52 Week Low
$4.00

Collections

AVDL Earnings

-$0.29
-$0.19
-$0.10
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 11, Pre-Market

You May Also Like

XPOA+
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure